Related Experiment Videos
[Metastatic mesenchymal chondrosarcoma]
Der Internist
|November 1, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author
Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors.
Naunyn-Schmiedeberg's archives of pharmacology·2001
Same author
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer.
The International journal of biological markers·2000
Same author
Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
Cardiovascular drugs and therapy·1998
Same author
Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y.
Journal of autonomic pharmacology·1997
Same author
Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
Naunyn-Schmiedeberg's archives of pharmacology·1996